BRCA2 and breast cancer: However, studies using a combination of p53 deletion and conditional Brca1 or Brca2 inactivation in skin and mammary gland epithelium (Xu et al, 1999; Jonkers et al, 2001) have demonstrated prevalent development of mammary tumours.